Replies to post #59694 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

These institutional studies are interesting, but they take on new meaning for DCVax-L, after Dr. Prins presentation that included CI + DCVax-L synergistic cancer killing effects in preclinical studies.

A renaissance, if you will, for potential DCVax-L + CI in other indications.

[CherryTree1]

Two of the patients in the DCVAX Direct trial had breast cancer.
http://www.nwbio.com/NWBTPhaciliate2016.pdf